Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
Holding APGE?
Track your performance easily

Apogee Therapeutics, Inc. (APGE) Cash flow

110 Followers

Apogee Therapeutics, Inc. Cash Flow

APGE's free cash flow for Q2 2024 was $-29.35M. For the 2024 fiscal year, APGE's free cash flow was decreased by $-58.54M and operating cash flow was $-29.30M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22
Operating Cash Flow
$ -95.35M$ -74.76M$ -16.43M
Investing Cash Flow
$ -434.67M$ -273.91M-
Financing Cash Flow
$ 765.97M$ 315.39M$ 168.32M
Cash Flow From Discontinued Operation
---
Other Cash Adjustment Inside Changein Cash
---
End Cash Position
$ 981.61M$ 118.61M$ 151.89M
Income Tax Paid Supplemental Data
---
Interest Paid Supplemental Data
---
Issuance Of Capital Stock
$ 765.56M$ 315.39M-
Issuance Of Debt
---
Repayment Of Debt
---
Free Cash Flow
$ -75.87M$ -74.97M$ -16.43M
Domestic Sales
---
Foreign Sales
---
Currency in USD

Apogee Therapeutics, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis